ReviewFrontiers in immunology2017

Alpha-Galactosylceramide/CD1d-Antibody Fusion Proteins Redirect Invariant Natural Killer T Cell Immunity to Solid Tumors and Promote Prolonged Therapeutic Responses.

Lianjun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.